These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11696094)

  • 41. In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
    Isenberg HD; Alperstein P; France K
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):115-8. PubMed ID: 9823535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Fritsche TR; Stilwell MG; Jones RN
    Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins.
    Dupuis M; Leclercq R
    Antimicrob Agents Chemother; 2006 Jan; 50(1):237-42. PubMed ID: 16377692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of gram positive cocci isolated from urine.
    Mathai E; Margaret A; George V; Brahmadathan KN
    Indian J Med Res; 1994 Jul; 100():10-4. PubMed ID: 7927545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
    Inoue M; Okamoto R; Okubo T; Inoue K; Mitsuhashi S
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():45-51. PubMed ID: 1399950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].
    Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Sugiyama T; Toyoshima S; Kato J; Watanabe N; Kaku M; Kanemitsu K; Kunishima H; Kawaguchi H; Okada J; Shimoyama N; Igari J; Oguri T; Kaimori M; Watanabe K; Kobayashi Y; Uchida H; Katayama Y; Sugimoto K; Tashiro H; Kanno H; Yasujima M; Itoh K; Suwabe A; Obata R; Okada M; Kobayashi S; Tsuzimura M; Itoh A; Sumitomo M; Taminato T; Negayama K; Baba H; Makino H; Murase M; Miyamoto H; Minakuchi K; Ishigo S; Takii M; Horii T; Ono J; Takata T; Yamanaka K; Hamazaki N; Tsutsui T; Okabe H; Tatewaki K; Moro K; Hiramatsu K; Saikawa T; Ichiyama S; Nagasawa Z; Aoki Y; Matsushima T; Niki Y; Hirakata Y; Kohno S; Kuwabara M; Nakagawa K; Kageoka T; Hongo T; Yamane N
    Jpn J Antibiot; 2003 Oct; 56(5):341-64. PubMed ID: 14692376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.
    Barry AL; Fuchs PC; Brown SD
    J Antimicrob Chemother; 1998 Nov; 42(5):651-5. PubMed ID: 9848451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): a novel orally administered streptogramin combination. The Quality Control Study Group.
    Putnam SD; Jones RN; Johnson DM
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):139-47. PubMed ID: 9294704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.
    Fuchs PC
    Am J Med; 1991 Dec; 91(6A):15S-18S. PubMed ID: 1662886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
    Jones RN; Mendes RE; Sader HS; Castanheira M
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci].
    Kuroyama M; Okamoto E; Yago K
    Jpn J Antibiot; 1998 Dec; 51(12):764-78. PubMed ID: 10077775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ; Beach ML; Jones RN
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In-vitro susceptibilites to levofloxacin and various antibacterial agents of 18,639 clinical isolates obtained from 77 centers in 2004].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M; Kanda M; Tsujio Y; Kimoto H; Kaimori M; Nakamura T; Kawamura C; Nishimura M; Akizawa K; Katayama Y; Matsuda K; Hayashi T; Yasujima M; Kasai T; Kimura M; Tominaga M; Miki M; Nakanowatari S; Nakagawa T; Kaku M; Kanemitsu K; Kunishima H; Toyoshima S; Sakurai M; Shiotani J; Sugita A; Ito T; Okada J; Suwabe A; Yamahata K; Yoneyama A; Kumasaka K; Yamane N; Koike K; Ieiri T; Kominami H; Yamada T; Oguri T; Itoh K; Watanabe K; Kobayashi Y; Ohtake T; Uchida T; Totsuka K; Murakami M; Yomoda S; Takahashi A; Okamoto H; Inuzuka K; Yamazaki K; Gonda H; Yamashita T; Yamaguchi I; Okada M; Ikari H; Kurosawa N; Fujimoto Y; Ishigo S; Asano Y; Mikio M; Kano I; Nagano E; Kageyama F; Shaku E; Kanno H; Aihara M; Gemma H; Uemura K; Miyajima E; Maesaki S; Hashikita G; Horii T; Sumitomo M; Yoshimura H; Hiraoka M; Wada H; Yuzuki Y; Ikeda N; Baba H; Soma M; Yamamoto T; Ichiyama S; Kinosita S; Kawano S; Fujita S; Kageoka T; Hongo T; Okabe H; Tatewaki K; Moro K; Oka M; Niki Y; Yoshida H; Yamashita M; Kusano N; Mihara E; Nose M; Fushiwaki T; Kuwabara M; Fujiue Y; Shimuzu A; Takubo T; Kusakabe T; Hinoda Y; Tanaka N; Takahashi H; Heijyou H; Okazaki T; Asai K; Kawahara K; Masuda J; Sano R; Taminato T; Negayama K; Matsuo S; Komatsu M; Sugiura T; Murase M; Hiramatsu K; Yamane N; Nakasone I; Hirakata Y; Kohno S; Aizawa H; Honda J; Hamazaki N; Okayama A; Ono J; Aoki Y; Okada K; Miyanohara H
    Jpn J Antibiot; 2006 Dec; 59(6):428-51. PubMed ID: 17334061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.
    Falagas ME; Roussos N; Gkegkes ID; Rafailidis PI; Karageorgopoulos DE
    Expert Opin Investig Drugs; 2009 Jul; 18(7):921-44. PubMed ID: 19548851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of new benzenesulphonamide fluoroquinolones structurally related to ciprofloxacin against selected ciprofloxacin-susceptible and -resistant Gram-positive cocci.
    Alovero F; Barnes A; Nieto M; Mazzieri MR; Manzo RH
    J Antimicrob Chemother; 2001 Nov; 48(5):709-12. PubMed ID: 11679560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance to the antimicrobial agents of bacteria isolated from non-sterile pharmaceuticals.
    de la Rosa MC; Mosso MA; García ML; Plaza C
    J Appl Bacteriol; 1993 May; 74(5):570-7. PubMed ID: 8486563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of vancomycin against recently isolated nosocomial gram-positive cocci.
    Maccanti O; Bonadio M
    Drugs Exp Clin Res; 1992; 18(7):295-7. PubMed ID: 1295722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.